• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

滤泡性皮疹作为新型冠状病毒肺炎的一种皮肤表现

Follicular eruption as a cutaneous manifestation in COVID-19.

作者信息

Danarti Retno, Budiarso Aries, Rini Dionisia Lintang Unggul, Soebono Hardyanto

机构信息

Department of Dermatology and Venereology, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia

Department of Dermatology and Venereology, Setjonegoro District Hospital, Wonosobo, Central Java, Indonesia.

出版信息

BMJ Case Rep. 2020 Oct 29;13(10):e238182. doi: 10.1136/bcr-2020-238182.

DOI:10.1136/bcr-2020-238182
PMID:33122237
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7597470/
Abstract

A 50-year-old man presented to our dermatology clinic with itchy skin rash. The rash began 5 days after systemic symptoms appeared such as mild fever and mild dyspnoea. The rashes were a characteristic of follicular eruption, which started on his stomach and spread all over his body. After a thorough evaluation, he was diagnosed with COVID-19 and was started on COVID-19 regimens. Skin lesions disappeared on the ninth day of treatment. Our findings contribute to the growing awareness of dermatological manifestations in patients with COVID-19.

摘要

一名50岁男性因皮肤瘙痒皮疹就诊于我们的皮肤科诊所。皮疹在出现轻度发热和轻度呼吸困难等全身症状5天后开始出现。皮疹具有毛囊疹的特征,始于他的腹部并蔓延至全身。经过全面评估,他被诊断为新冠肺炎,并开始接受新冠肺炎治疗方案。皮肤病变在治疗的第九天消失。我们的发现有助于提高对新冠肺炎患者皮肤表现的认识。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd45/7597470/a9f2aae418c5/bcr-2020-238182f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd45/7597470/a9f2aae418c5/bcr-2020-238182f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd45/7597470/a9f2aae418c5/bcr-2020-238182f01.jpg

相似文献

1
Follicular eruption as a cutaneous manifestation in COVID-19.滤泡性皮疹作为新型冠状病毒肺炎的一种皮肤表现
BMJ Case Rep. 2020 Oct 29;13(10):e238182. doi: 10.1136/bcr-2020-238182.
2
Cutaneous manifestations of COVID-19: Report of three cases and a review of literature.COVID-19 的皮肤表现:三例病例报告及文献复习。
J Dermatol Sci. 2020 May;98(2):75-81. doi: 10.1016/j.jdermsci.2020.04.011. Epub 2020 Apr 29.
3
Clinical features and treatment of COVID-19 patients in northeast Chongqing.重庆东北部地区 COVID-19 患者的临床特征和治疗方法。
J Med Virol. 2020 Jul;92(7):797-806. doi: 10.1002/jmv.25783. Epub 2020 Apr 1.
4
COVID-19: how it can look on the skin. Clinical and pathological features in 20 COVID-19 patients observed in Bologna, north-eastern Italy.新型冠状病毒肺炎:其在皮肤上的表现。意大利东北部博洛尼亚观察的20例新型冠状病毒肺炎患者的临床及病理特征
J Eur Acad Dermatol Venereol. 2020 Oct;34(10):e552-e553. doi: 10.1111/jdv.16693. Epub 2020 Jun 25.
5
Skin manifestations associated with the new coronavirus SARS-CoV-2 disease.与新型冠状病毒SARS-CoV-2疾病相关的皮肤表现。
Med Clin (Barc). 2020 Nov 13;155(9):414-415. doi: 10.1016/j.medcli.2020.04.057. Epub 2020 Jul 24.
6
Late manifestation of follicular conjunctivitis in ventilated patient following COVID-19 positive severe pneumonia.COVID-19 阳性重症肺炎患者机械通气后滤泡性结膜炎的迟发表现。
Indian J Ophthalmol. 2020 Aug;68(8):1675-1677. doi: 10.4103/ijo.IJO_1682_20.
7
Post-COVID-19 pneumonia pulmonary fibrosis.新型冠状病毒肺炎后肺纤维化
QJM. 2020 Nov 1;113(11):837-838. doi: 10.1093/qjmed/hcaa255.
8
Two cases of skin manifestations prior to the onset of COVID-19 respiratory symptoms.两例在COVID-19呼吸道症状出现之前出现皮肤表现的病例。
Int J Dermatol. 2020 Dec;59(12):1541-1542. doi: 10.1111/ijd.15247. Epub 2020 Oct 20.
9
Rash as a presenting complaint in a child with COVID-19.皮疹作为新冠病毒感染儿童的首发症状。
Pediatr Dermatol. 2020 Sep;37(5):966-967. doi: 10.1111/pde.14257. Epub 2020 Jul 16.
10
An itchy erythematous papular skin rash as a possible early sign of COVID-19: a case report.一种可能作为新型冠状病毒肺炎早期体征的瘙痒性红斑丘疹性皮疹:一例病例报告
J Med Case Rep. 2020 Nov 9;14(1):216. doi: 10.1186/s13256-020-02538-y.

引用本文的文献

1
Cutaneous Manifestation in COVID-19: A Lesson Over 2 Years Into the Pandemic.COVID-19 相关皮肤表现:大流行 2 年多来的教训。
Clin Med Res. 2023 Mar;21(1):36-45. doi: 10.3121/cmr.2023.1598.
2
A systematic review of dermatologic manifestations among adult patients with COVID-19 diagnosis.对确诊为COVID-19的成年患者皮肤表现的系统评价。
Skin Health Dis. 2021 Jun;1(2):e20. doi: 10.1002/ski2.20. Epub 2021 Mar 19.

本文引用的文献

1
Cutaneous manifestations in patients with COVID-19: a preliminary review of an emerging issue.新型冠状病毒肺炎患者的皮肤表现:一个新出现问题的初步综述
Br J Dermatol. 2020 Sep;183(3):431-442. doi: 10.1111/bjd.19264. Epub 2020 Jul 5.
2
Cutaneous manifestations of COVID-19: A review of the published literature.COVID-19 的皮肤表现:已发表文献综述。
Dermatol Ther. 2020 Jul;33(4):e13696. doi: 10.1111/dth.13696. Epub 2020 Jun 24.
3
Cutaneous signs in COVID-19 patients: A review.COVID-19 患者的皮肤表现:综述。
Dermatol Ther. 2020 Sep;33(5):e13549. doi: 10.1111/dth.13549. Epub 2020 May 29.
4
Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases.COVID-19 皮肤表现分类:西班牙 375 例快速前瞻性全国共识研究。
Br J Dermatol. 2020 Jul;183(1):71-77. doi: 10.1111/bjd.19163. Epub 2020 Jun 10.
5
Comment on 'Cutaneous manifestations in COVID-19: a first perspective' by Recalcati S.对雷卡尔卡蒂·S所著《2019冠状病毒病的皮肤表现:初步观点》的评论
J Eur Acad Dermatol Venereol. 2020 Jul;34(7):e299-e300. doi: 10.1111/jdv.16519.
6
Cutaneous manifestations in COVID-19: a first perspective.新型冠状病毒肺炎的皮肤表现:初步观点
J Eur Acad Dermatol Venereol. 2020 May;34(5):e212-e213. doi: 10.1111/jdv.16387.
7
Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany.德国一名无症状接触者传播2019新型冠状病毒感染
N Engl J Med. 2020 Mar 5;382(10):970-971. doi: 10.1056/NEJMc2001468. Epub 2020 Jan 30.
8
Febrile Illness with Skin Rashes.伴有皮疹的发热性疾病
Infect Chemother. 2015 Sep;47(3):155-66. doi: 10.3947/ic.2015.47.3.155. Epub 2015 Sep 30.
9
[Cold urticaria associated with Epstein barr virus mononucleosis].[与爱泼斯坦-巴尔病毒单核细胞增多症相关的寒冷性荨麻疹]
Actas Dermosifiliogr. 2009 Jun;100(5):435-6. doi: 10.1016/s0001-7310(09)71265-7.
10
Cold urticaria and HIV infection.
Br J Dermatol. 1993 Oct;129(4):465-7. doi: 10.1111/j.1365-2133.1993.tb03179.x.